Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Acta Pharmaceutica Sinica. B|March 15, 2024
Late-stage modification of bioactive compounds: Improving druggability through efficient molecular editingTongyu Huo, Xinyi Zhao, Zengrui Cheng, et al.Journal of Medicinal Chemistry|February 19, 2026
Discovery of N-Ethyl Sulfonamide Derivatives as Potent Intestinal-Restricted Farnesoid X Receptor Antagonists for the Treatment of Metabolic DisordersLingyu Su, Tongyu Huo, Xinyi Zhao, et al.Organic Letters|December 13, 2018
Rh-Catalyzed Reaction of Vinyl Azides with Isonitriles and Alkynes/BenzynesZongyang Li, Tongyu Huo, Li Li, et al.European Journal of Medicinal Chemistry|March 28, 2024
Discovery of novel and selective farnesoid X receptor antagonists through structure-based virtual screening, preliminary structure-activity relationship study, and biological evaluationXiaodong Dou, Tongyu Huo, Yameng Liu, et al.Bioorganic & Medicinal Chemistry Letters|November 9, 2023
Discovery of 3-oxo-1,2,3,4-tetrahydropyrido[1,2-a]pyrazin derivatives as SARS-CoV-2 main protease inhibitors through virtual screening and biological evaluationXiaodong Dou, Qi Sun, Yameng Liu, et al.Acta Pharmaceutica Sinica. B|June 29, 2026
Discovery of sulfonyl benzoic acid derivatives with joint TGR5-agonist and FXR-antagonist activity for myocardial ischemia/reperfusion injury protectionXinyi Zhao, Tianqi Chang, Xiang Wu, et al.European Journal of Medicinal Chemistry|June 10, 2022
Discovery of 2-(furan-2-ylmethylene)hydrazine-1-carbothioamide derivatives as novel inhibitors of SARS-CoV-2 main proteaseXiaodong Dou, Qi Sun, Guofeng Xu, et al.Pageof 1